In 2022, around 78 percent of all over-the-counter (OTC) drugs produced in South Korea were administered by oral intake. The remaining 22 percent were intended for external use or other routes of administration. They were no injectable OTC drugs produced that year.
Distribution of administration routes of over-the-counter (OTC) pharmaceutical drug produced in South Korea in 2022, by production value share
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2022
- Basic Statistic Pharmaceutical sales of Recordati 2022, by region
- Premium Statistic OTC pain relief medicines: breakdown of sales in Great Britain, by category
- Premium Statistic Distribution of the pharmaceutical market in China
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2022
- Basic Statistic OTC pain relief treatments sales value in Great Britain 2009-2023
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Premium Statistic Sideral market share out of the total iron supplement market value 2008-2022
- Premium Statistic Sideral market share out of total food supplements market value in Italy 2008-2022
About the region
10
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Premium Statistic Leading pharmaceutical companies South Korea 2022, by production value
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
Selected statistics
6
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Premium Statistic Revenue of the analgesics industry in Italy 2017-2028
- Premium Statistic Genomma Lab: EBITDA 2013-2018
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
- Premium Statistic Most sold healing pharmaceutical cosmetic brands in Russia 2022
- Basic Statistic Medical goods: monthly retail sales value index in Great Britain 2016-2023
- Premium Statistic Pharmaceutical sales in Argentina 2010-2021, by type
- Basic Statistic Pharmaceutical revenue in Norway 2012-2021
- Basic Statistic Medicine spending in emerging pharmaceutical markets 2026
- Basic Statistic Self-medication market sales of analgesics in Europe in 2020, by country
- Premium Statistic Sales value market share of food supplements sector in Europe 2009-2020, by country
Related statistics
10
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Yuhan 2015-2022
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
- Premium Statistic Traditional medicine industry South Korea 2021, by sales revenue
- Premium Statistic Traditional medicine industry sales in South Korea 2021, by sector
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Premium Statistic Pharmaceutical export value from South Korea 2012-2022
Further related statistics
10
- Pfizer's revenues in the U.S. and abroad 2009-2023
- U.S. branded prescription revenue forecast 2009-2015
- Sanofi's total assets 2007-2023
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- M&A capacities - changes for the global pharma industry 2008-2015
- Merck & Co total assets 2009-2023
Further Content: You might find this interesting as well
Statistics
- Pfizer's revenues in the U.S. and abroad 2009-2023
- U.S. branded prescription revenue forecast 2009-2015
- Sanofi's total assets 2007-2023
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- M&A capacities - changes for the global pharma industry 2008-2015
- Merck & Co total assets 2009-2023
HIRA. (June 26, 2023). Distribution of administration routes of over-the-counter (OTC) pharmaceutical drug produced in South Korea in 2022, by production value share [Graph]. In Statista. Retrieved April 20, 2024, from https://www.statista.com/statistics/1323412/south-korea-otc-drug-administrative-route-distribution-by-production-value/
HIRA. "Distribution of administration routes of over-the-counter (OTC) pharmaceutical drug produced in South Korea in 2022, by production value share." Chart. June 26, 2023. Statista. Accessed April 20, 2024. https://www.statista.com/statistics/1323412/south-korea-otc-drug-administrative-route-distribution-by-production-value/
HIRA. (2023). Distribution of administration routes of over-the-counter (OTC) pharmaceutical drug produced in South Korea in 2022, by production value share. Statista. Statista Inc.. Accessed: April 20, 2024. https://www.statista.com/statistics/1323412/south-korea-otc-drug-administrative-route-distribution-by-production-value/
HIRA. "Distribution of Administration Routes of Over-the-counter (Otc) Pharmaceutical Drug Produced in South Korea in 2022, by Production Value Share." Statista, Statista Inc., 26 Jun 2023, https://www.statista.com/statistics/1323412/south-korea-otc-drug-administrative-route-distribution-by-production-value/
HIRA, Distribution of administration routes of over-the-counter (OTC) pharmaceutical drug produced in South Korea in 2022, by production value share Statista, https://www.statista.com/statistics/1323412/south-korea-otc-drug-administrative-route-distribution-by-production-value/ (last visited April 20, 2024)
Distribution of administration routes of over-the-counter (OTC) pharmaceutical drug produced in South Korea in 2022, by production value share [Graph], HIRA, June 26, 2023. [Online]. Available: https://www.statista.com/statistics/1323412/south-korea-otc-drug-administrative-route-distribution-by-production-value/